| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/01/2009 | US7626030 Compounds and methods of use |
| 12/01/2009 | US7626027 phosphorylation activity; CNS mood disorders (major depressive disorder, bipolar I and II disorders), sleep disorders (circadian rhythm - shift work, jet lag), advanced and delayed sleep phase; reaction of a chloronitropyridine and diethyl malonate; decarboxylation, cyclization |
| 12/01/2009 | US7626026 Pyrrolo-indole and pyrrolo-quinoline derivatives as prodrugs for tumour treatment |
| 12/01/2009 | US7626025 Isolated from Indian ascidian Synoicum macroglossum by solvent extraction; chromatography; for treatment of diabetic disorders by providing inhibition of alpha (alpha)glucosidase |
| 12/01/2009 | US7626023 Compounds for treating tumors |
| 12/01/2009 | US7626014 improved pharmacokinetics; gene silencing; phosphorothioate linkages; naproxen and ibuprofen as ligands |
| 12/01/2009 | US7626012 Nucleic acids encoding monoclonal antibody or an antigen-binding portion thereof that specifically binds to and activates human CD40; Gene therapy; nucleic acid coding immunoglobulins; anticancer agents |
| 12/01/2009 | US7626007 Comprises DNA binding polypeptide for prevention and treatment of oral, arthritic, inflammatory, cancer and infectious diseases |
| 12/01/2009 | US7626005 Antibiotic resistance |
| 12/01/2009 | US7625950 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator |
| 12/01/2009 | US7625949 administering a drug having formula of 2-[4-chloro-3-(3-chloro-5-cyano-phenoxy)-2-fluoro-phenyl]-N-(2-chloro4-sulfamoyl-phenyl)-acetamide for treating an HIV infection |
| 12/01/2009 | US7625948 Ester that inhibits MTP in intestines as antilipemic agents for side effect reduction |
| 12/01/2009 | US7625947 5-Lipoxygenase inhibitor for treating inflammations and hypersensitivity-based human diseases including asthma, arthritis, bowel diseases such as ulcerative colitis and circulatory disorders such as shock and ischaemia; antiinflammatory agent, antitumor agent |
| 12/01/2009 | US7625945 Andrographolide and analogues as inhibitors of TNFα and IL-1β expression |
| 12/01/2009 | US7625944 carbamimidoyl benzylamide derivatives; preventing and treating the formation of thrombin during or after a PK dependent disease or condition after fibrinolysis treatment |
| 12/01/2009 | US7625943 5-alkyl-7-alkylcarbonate-isoflavone ester and related method |
| 12/01/2009 | US7625942 Method of treating Down syndrome |
| 12/01/2009 | US7625941 N-substituted pyrrolidinone having a separated pendant ammonium cation by a variable length alkyl spacer and fluoroalkyl sulfonate anions; environmentally friendly solvent; catalysts for reactions, including nitration, acylation, esterification, etherification |
| 12/01/2009 | US7625940 Method of treating hypertension with a very low dose of chlorthalidone |
| 12/01/2009 | US7625939 Cyclopropyl-fused pyrrolidine derivatives as dipeptidyl peptidase IV inhibitors |
| 12/01/2009 | US7625938 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 12/01/2009 | US7625937 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators |
| 12/01/2009 | US7625936 Mitotic kinesin inhibitors |
| 12/01/2009 | US7625935 fungicides; good yields; steps require neither solvents nor reactants that are highly flammable and explosive, carcinogenic or corrosive; 1-chloro-4-chlorophenyl-2-butanol is reacted with the imidazole in toluene and aqueous sodium hydroxide solution in the presence of a phase transfer catalyst |
| 12/01/2009 | US7625934 Metalloproteinase inhibitors |
| 12/01/2009 | US7625933 PPAR gamma agonists or partial agonists; type II diabetes, including hyperglycemia, dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity; compounds have a thiazolidinedione or an oxazolidinedione substituent |
| 12/01/2009 | US7625932 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 12/01/2009 | US7625931 Certain substituted diphenyl ureas, as modulators of kinase activity |
| 12/01/2009 | US7625930 Chromophoric moiety comprises trialkoxyphenylpyridyl groups; biochemical conjugation; for solid phase synthesis of oligonucleotides and oligopeptides; magnetic resonance imaging; positron emission tomography |
| 12/01/2009 | US7625929 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
| 12/01/2009 | US7625928 Prevent, therapy of side effect of radiotherapy; applying to skins, mucous membranes |
| 12/01/2009 | US7625927 Method of treating glaucoma |
| 12/01/2009 | US7625926 P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same |
| 12/01/2009 | US7625925 Pyrazolo[1,5-a]pyridines and medicines containing the same |
| 12/01/2009 | US7625924 Nicotinic alpha-7 receptor ligands and preparation and uses thereof |
| 12/01/2009 | US7625923 -4-[7-(hydroxy)-tetrahydro-pyrrolo[1,2-c]oxazol-3-ylideneamino]-2-chloro-3-methyl-benzonitrile; non-steroidal, non-toxic; side effect reduction; aging resistance; sarcopenia, osteoporosis and osteopenia, osteoporosis and osteopenia, cancer cachexia, eating disorders (e.g., anorexia) and chemotherapy |
| 12/01/2009 | US7625922 Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds |
| 12/01/2009 | US7625921 Bridged ring compounds based on nitrogen-containing rings such as 5,10-dihydro-5,10-ethanobenzo(g)quinoline; treating obesity, diabetes and inflammatory or immune associated diseases; nuclear factor kappa beta (NF-KB) |
| 12/01/2009 | US7625920 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 12/01/2009 | US7625919 Osteoporosis; oral diseases; bone disorders; atherosclerosis; antiarthritic agents; autoimmune disease; cachexia |
| 12/01/2009 | US7625918 pure physical form of hydrocodone bitartrate; analgesic agents |
| 12/01/2009 | US7625917 S-o-(phenylaminocarbonyl)phenyl-substituted, especially with a quaternary onium group; enhanced antiviral activity and better reactivity with zinc finger moieties, particularly, the zinc finger on HIV-1's NCp7 nucleocapsid protein |
| 12/01/2009 | US7625916 Medicinal composition |
| 12/01/2009 | US7625915 treating colon cancer comprising administering N-(1-(4-Methoxyphenyl)-3-tert-butyl-5-pyrazolyl)-N'-(2,3-dichlorophenyl)urea; antitumor, anticarcinogenic, antiproliferative agent; ras protein signal transduction cascade related cancer |
| 12/01/2009 | US7625914 2(S)-Ethoxy-3-{4-[2-(3-heptyl-1-methylureido)thiazol-4-yl]phenyl}propanoic acid; dermatology, and cardiovascular diseases, immune diseases, lipid metabolism diseases; veterinary medicine |
| 12/01/2009 | US7625913 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 12/01/2009 | US7625912 2-Phenylpyrimidinone compounds; anticarcinogenic agents can be synergistically combined with one or more active ingredients such as paclitaxel or trastuzumab; side effect reduction |
| 12/01/2009 | US7625911 Amorphous form of erlotinib hydrochloride and its solid amorphous dispersion |
| 12/01/2009 | US7625910 aurora kinase inhibitor is for the treatment of cancer; 2-{ethyl[3-({4-[(5-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-3-yl)amino]quinazolin-7-yl}oxy)propyl]amino}ethyl dihydrogen phosphate; anticarcinogenic agents |
| 12/01/2009 | US7625909 N-{3-[2-(2-Fluoro-4-methoxyphenyl)-ethyl]-4-oxo-3,4-dihydroquinazolin-7yl}-N-indan-2-yl-3,5-dimethylpiperazine-1-carboxamidine; melanocortin-4 receptor agonists; diabetes |
| 12/01/2009 | US7625908 Antiproliferative agent in the prevention or treatment of tumors which are sensitive to inhibition of EGF and erbB receptor tyrosine kinases;1-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}methyl)-L-prolinamide |
| 12/01/2009 | US7625907 administering a drug of 1,5-bis(3-nitrooxypropyl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one, for heart failure and stable angina, cardiovascular disorders |
| 12/01/2009 | US7625906 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 12/01/2009 | US7625905 Octahydro-pyrrolo[3,4-c]pyrrole CCR5 receptor antagonists |
| 12/01/2009 | US7625904 Methods for the treatment of sleep disorders |
| 12/01/2009 | US7625903 Anticancer agent; N-(1-methylethyl)-2-[(5-methyl-2-{[3-(4-methyl-2-oxo-1-piperazinyl)phenyl]amino}-4-pyrimidinyl)amino]benzamide |
| 12/01/2009 | US7625902 improved pharmacological properties like metabolic stability, selectivity, bioavailability and activity; Liver-X-Receptors modulators; to treat increased lipid and cholesterol levels; 4-[4-(2,5-Dimethyl-phenyl)-piperazine-1-carbonyl]-1-(3-methoxy-benzenesulfonyl)-3-phenyl-imidazolidin-2-one |
| 12/01/2009 | US7625901 for treating migraine, headaches; 2-[(8S)-8-(3,5-Difluorophenyl)-6-oxo-7-azaspiro[4.5]dec-7-yl]-N-(2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-2-yl)acetamide |
| 12/01/2009 | US7625900 Analgesics; potassium channel moderators; headaches; antiepileptic agents; psychological disorders; incontinence; neuropathic pain |
| 12/01/2009 | US7625899 antiproliferative, antitumor and anticarcinogenic agent; cyclin dependent kinase inhibitor |
| 12/01/2009 | US7625897 5-[6-Chloro-2-fluoro-3-((R)-5-methyl-6-oxo-1,4,5,6-tetrahydro-[1,2,4]triazin-3-ylmethyl)-phenoxy]-isophthalonitrile; contacting a phenylacetic acid compound with an amino acid ester in presence of a coupling reagent to produce an intermediate, then with Lawesson's reagent, finally with hydrazine; AIDS |
| 12/01/2009 | US7625896 Pyridylsulfonamide derivatives |
| 12/01/2009 | US7625895 e.g. 5-[rac-cis-2,3-Bis-(4-chloro-phenyl)-5-oxo-2,3-dihydro-5H-imidazo[1,2-a]pyridine-1-sulfonyl]-2-fluoro-benzonitrile; inhibit the interaction of tumor suppressor MDM2 protein with a p53-like peptide; antiproliferative agent; cycle arrest in G1 and G2 phase |
| 12/01/2009 | US7625894 Pyrrolo[2,3-d]Pyrimidines as Protein Tyrosine Kinase Inhibitors |
| 12/01/2009 | US7625893 (3S,4R,5R)-3-hydroxymethyl-4-[4-((S)-3-methoxy-2-methyl-propoxymethyl)-phenyl]-5-[4-(3-methoxy-propyl)-3,4-dihydro-2H-benzo [1,4]oxazin-6-ylmethoxy]-piperidine-1-carboxylic acid benzyl ester; improvement of the pharmacokinetic properties; better bioavailability |
| 12/01/2009 | US7625892 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 12/01/2009 | US7625891 4-{2-[5-(4,6-Dimethyl-pyrimidine-5-carbonyl)-hexahydro-pyrrolo[3,4-c]pyrrol-2-yl]-ethyl}-4-phenyl-piperidine-1-carboxylic acid tert-butyl ester,chemokine receptor antagonist; human immunodeficiency virus (HIV) infection, AIDS or ARC, antiinflammatory agent, autoimmune diseases, graft v. host disease |
| 12/01/2009 | US7625890 Substituted imidazo[4,5-c]pyridine compounds as Akt inhibitors |
| 12/01/2009 | US7625889 Substituted bis aryl and heteroaryl compounds as selective 5HT2A antagonists |
| 12/01/2009 | US7625888 {(1R)-1-(2,4,5-Trifluorobenzyl)-2-[9-(trifluoromethyl)-5,6-dihydrobis[1,2,4]triazolo[1,5-a:3',4'-c]pyrazin-3-yl]ethyl}amine, hydrochloride; metformin; treating non-insulin dependent (Type 2) diabetes in a mammal |
| 12/01/2009 | US7625887 e.g. 2-[3,5-trans-5-(3-aminophenyl)-7-chloro-1-neopentyl-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-N-(2-fluorobenzyl)acetamide; G-protein-coupled receptor (TGR5) agonist; central nervous system diseases; antiinflammatory agent; learning enhancement; angina pectoris, arrhythmia, bronchial asthma |
| 12/01/2009 | US7625886 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions |
| 12/01/2009 | US7625885 administering Palmerolides, macrocyclic polyketides bearing carbamate and a vinyl amide or aldehyde functionality; extracts from the tunicate Synoicum adareanum, used for treatment of melanoma, colon and renal cancer; anticarcinogenic agents |
| 12/01/2009 | US7625884 Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
| 12/01/2009 | US7625883 Choline Salt of L- alpha -glycero-phospho-D-mio-inositol; alpha -glycero-phospho-D-mio-inositol tetrabutylammonium salt; treatment of pathologies mediated by the activation or over stimulation of cytololilc phospholipase-2 (PLA2), particularly, septic shock and viral and bacterial infections |
| 12/01/2009 | US7625882 Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
| 12/01/2009 | US7625881 3-ethyl-2,6-dioxo-1-propyl-8-(1-{[3-(trifluoromethyl)phenyl]methyl}pyrazol-4-yl)-1,3,7-trihydropurin-7-yl]methyl butanoate; treatment of asthma and diarrhea |
| 12/01/2009 | US7625880 2-(4-fluoro-2-methylphenylamino)-1,6-dimethyl-7-[3-(4-methyl-4-oxo-4 lambda 5[1,4]azaphosphinan-1-yl)-propenyl]-1,8-dihydro-imidazo[4,5-h]isoquinolin-9-one; anticancer agents, antiinflammatory agents, antiviral agents, anti-thromboembolic agents, as well as for treating autoimmune disease |
| 12/01/2009 | US7625879 Phosphohalohydrins, process for the production thereof and use thereof |
| 12/01/2009 | US7625878 Sulfoalkyl ether-alkyl ether cyclodextrin derivatives |
| 12/01/2009 | US7625877 Acquired Immune Deficiency Syndrome (AIDS); 2'-deoxy-4'-C-ethynyl-2-fluoroadenosine; anti-HIV activity, particularly against a multi-drug-resistant HIV strain; less cytotoxicity, exhibit resistance to inactivation by adenosine deaminase |
| 12/01/2009 | US7625876 Reducing toxicity associated with 6-mercaptopurine drug treatment via monitoring concentration of 6-thioguanine in blood; treating inflammatory bowel disease |
| 12/01/2009 | US7625875 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections |
| 12/01/2009 | US7625872 a branch-point nucleoside to which three core nucleic acid moieties are covalently coupled; therapy for cancer and Th2-type immune response (e.g., an allergy or allergy-induced asthma) by increasing the secretion of interferon-gamma |
| 12/01/2009 | US7625871 e.g. 5,6-Dichloro-2-dimethylamino-3-formyl-1-(2,3-O-isopropylidene- beta -D-ribofuranosyl)indole; cytomegalovirus infection, hepatitis B virus infection, herpes simplex virus type 1 infection, varicella zoster virus infection, Epstein Barr virus infection, human herpes virus ; |
| 12/01/2009 | US7625861 Copolymer-1 improvements in compositions of copolymers |
| 12/01/2009 | US7625860 Administering a combination of a cytotoxic agent and a fibroblastic growth factor antagonist, wherein the FGF antagonist enhances the efficacy of the cytotoxic agent |
| 12/01/2009 | US7625751 WNV core protein/capsid interacting protein and uses of the same |
| 12/01/2009 | US7625750 Compositions for DNA mediated gene silencing |
| 12/01/2009 | US7625710 Methods for determining 2F1-binding compounds |
| 12/01/2009 | US7625696 Method and screening kit using a GPR30 receptor and a ligand capable of specifically binding to receptor, a compound which is obtainable using screening method or kit; particularly relates to screening method and screening kit for prevention/treatment of cancer, heart disease |
| 12/01/2009 | US7625583 Microbiocidal fatty acids such as palmitoleic acid and lauric acid |
| 12/01/2009 | US7625582 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| 12/01/2009 | US7625581 Porous substrate comprising a biodegradable, hydrophobic polymer and a hyaluronic acid complex incorporated with the substrate, wherein the hyaluronic acid complex is insoluble in water, yet soluble in mixtures of organic and aqueous solvents in which the hydrophobic polymer is soluble |
| 12/01/2009 | US7625579 A substrate having a vapor deposited furanone compounds, covalent bonding through etherification or amination; protective coatings on medical equipment, seeds, fibrics, wool, hair, silk, cotton, chitin, collagen, animal |
| 12/01/2009 | US7625561 Diabody which specifically binds Streptococcus surface antigen I/II and methods of use thereof |
| 12/01/2009 | US7625554 Treatment of alzheimer's disease |
| 12/01/2009 | US7625552 Bioactive polymers for imparting bioactive character to hydrophobic medical article surfaces |
| 12/01/2009 | US7625548 Methods and apparatus for producing nanoscale particles |
| 12/01/2009 | US7625507 Extrusion/melt-congeal process; reduced drug degradation |